Apollomics, Inc. (APLM)
NASDAQ: APLM · Real-Time Price · USD
16.27
+1.52 (10.31%)
At close: Dec 5, 2025, 4:00 PM EST
17.04
+0.77 (4.72%)
After-hours: Dec 5, 2025, 7:54 PM EST
Apollomics Market Cap
Apollomics has a market cap or net worth of $34.92 million as of December 5, 2025. Its market cap has increased by 147.87% in one year.
Market Cap
34.92M
Enterprise Value
26.10M
1-Year Change
147.87%
Ranking
Category
Stock Price
$16.27
Market Cap Chart
Since November 26, 2021, Apollomics's market cap has decreased from $129.59M to $34.92M, a decrease of -73.06%. That is a compound annual growth rate of -27.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 31.64M | 194.35% |
| Dec 31, 2024 | 10.75M | -87.56% |
| Dec 29, 2023 | 86.40M | -37.89% |
| Dec 30, 2022 | 139.11M | 7.02% |
| Dec 30, 2021 | 129.98M | 0.30% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |